Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

INZY Inozyme Pharma Inc

4,54

-0,11 (-2,37%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Inozyme Pharma (NASDAQ:INZY)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Inozyme Pharma Charts.

Inozyme Pharma (NASDAQ:INZY)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Inozyme Pharma Charts.

News Inozyme Pharma Inc

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
Mittwoch 8 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
Dienstag 7 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
Montag 8 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Samstag 6 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference
Dienstag 2 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
Dienstag 26 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference
Montag 26 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Inozyme Pharma Inc News-Artikel

JP Morgan Chase

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen